Buscar
Mostrando ítems 21-30 de 33
Lopinavir, an HIV-1 peptidase inhibitor, induces alteration on the lipid metabolism of Leishmania amazonensis promastigotes
(Cambridge University Press, 2018)
Lopinavir, an HIV-1 peptidase inhibitor, induces alteration on the lipid metabolism of Leishmania amazonensis promastigotes
(Cambridge University Press, 2018)
Secretory Leukocyte Protease Inhibitor Expression and High-Risk HPV Infection in Anal Lesions of HIV-Positive Patients
(Lippincott, Williams & Wilkins, 2018)
SLPI (secretory leukocyte peptidase inhibitor)
(University Hospital of Poitiers, 2015-08)
Secretory Leukocyte Peptidase Inhibitor (SLPI) functionality in health and disease: Secretory Leukocyte Peptidase Inhibitor (SLPI) is a serine protease inhibitor of cathepsin G, trypsin and chymotrypsin, but primarily ...
Chagas disease treatment: From new therapeutic targets to drug discovery and repositioning
(Bentham Science Publishers, 2019-12)
Chagas disease, caused by the protozoan Trypanosoma cruzi, currently affects millions of people worldwide although it is only endemic in America. Chagas is considered a neglected tropical disease because it afflicts the ...